Cargando…
Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients
RATIONALE: There is mounting evidence of a higher incidence of coronary heart disease in cytomegalovirus-seropositive individuals. OBJECTIVE: The aim of this study was to investigate whether acute myocardial infarction triggers an inflammatory T-cell response that might lead to accelerated immunosen...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280279/ https://www.ncbi.nlm.nih.gov/pubmed/25385851 http://dx.doi.org/10.1161/CIRCRESAHA.116.304393 |
_version_ | 1782350832030711808 |
---|---|
author | Hoffmann, Jedrzej Shmeleva, Evgeniya V. Boag, Stephen E. Fiser, Karel Bagnall, Alan Murali, Santosh Dimmick, Ian Pircher, Hanspeter Martin-Ruiz, Carmen Egred, Mohaned Keavney, Bernard von Zglinicki, Thomas Das, Rajiv Todryk, Stephen Spyridopoulos, Ioakim |
author_facet | Hoffmann, Jedrzej Shmeleva, Evgeniya V. Boag, Stephen E. Fiser, Karel Bagnall, Alan Murali, Santosh Dimmick, Ian Pircher, Hanspeter Martin-Ruiz, Carmen Egred, Mohaned Keavney, Bernard von Zglinicki, Thomas Das, Rajiv Todryk, Stephen Spyridopoulos, Ioakim |
author_sort | Hoffmann, Jedrzej |
collection | PubMed |
description | RATIONALE: There is mounting evidence of a higher incidence of coronary heart disease in cytomegalovirus-seropositive individuals. OBJECTIVE: The aim of this study was to investigate whether acute myocardial infarction triggers an inflammatory T-cell response that might lead to accelerated immunosenescence in cytomegalovirus-seropositive patients. METHODS AND RESULTS: Thirty-four patients with acute myocardial infarction undergoing primary percutaneous coronary intervention were longitudinally studied within 3 months after reperfusion (Cohort A). In addition, 54 patients with acute myocardial infarction and chronic myocardial infarction were analyzed in a cross-sectional study (Cohort B). Cytomegalovirus-seropositive patients demonstrated a greater fall in the concentration of terminally differentiated CD8 effector memory T cells (T(EMRA)) in peripheral blood during the first 30 minutes of reperfusion compared with cytomegalovirus-seronegative patients (−192 versus −63 cells/μL; P=0.008), correlating with the expression of programmed cell death-1 before primary percutaneous coronary intervention (r=0.8; P=0.0002). A significant proportion of T(EMRA) cells remained depleted for ≥3 months in cytomegalovirus-seropositive patients. Using high-throughput 13-parameter flow cytometry and human leukocyte antigen class I cytomegalovirus-specific dextramers, we confirmed an acute and persistent depletion of terminally differentiated T(EMRA) and cytomegalovirus-specific CD8(+) cells in cytomegalovirus-seropositive patients. Long-term reconstitution of the T(EMRA) pool in chronic cytomegalovirus-seropositive postmyocardial infarction patients was associated with signs of terminal differentiation including an increase in killer cell lectin-like receptor subfamily G member 1 and shorter telomere length in CD8(+) T cells (2225 versus 3397 bp; P<0.001). CONCLUSIONS: Myocardial ischemia and reperfusion in cytomegalovirus-seropositive patients undergoing primary percutaneous coronary intervention leads to acute loss of antigen-specific, terminally differentiated CD8 T cells, possibly through programmed cell death-1–dependent programmed cell death. Our results suggest that acute myocardial infarction and reperfusion accelerate immunosenescence in cytomegalovirus-seropositive patients. |
format | Online Article Text |
id | pubmed-4280279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-42802792015-01-06 Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients Hoffmann, Jedrzej Shmeleva, Evgeniya V. Boag, Stephen E. Fiser, Karel Bagnall, Alan Murali, Santosh Dimmick, Ian Pircher, Hanspeter Martin-Ruiz, Carmen Egred, Mohaned Keavney, Bernard von Zglinicki, Thomas Das, Rajiv Todryk, Stephen Spyridopoulos, Ioakim Circ Res Clinical Track RATIONALE: There is mounting evidence of a higher incidence of coronary heart disease in cytomegalovirus-seropositive individuals. OBJECTIVE: The aim of this study was to investigate whether acute myocardial infarction triggers an inflammatory T-cell response that might lead to accelerated immunosenescence in cytomegalovirus-seropositive patients. METHODS AND RESULTS: Thirty-four patients with acute myocardial infarction undergoing primary percutaneous coronary intervention were longitudinally studied within 3 months after reperfusion (Cohort A). In addition, 54 patients with acute myocardial infarction and chronic myocardial infarction were analyzed in a cross-sectional study (Cohort B). Cytomegalovirus-seropositive patients demonstrated a greater fall in the concentration of terminally differentiated CD8 effector memory T cells (T(EMRA)) in peripheral blood during the first 30 minutes of reperfusion compared with cytomegalovirus-seronegative patients (−192 versus −63 cells/μL; P=0.008), correlating with the expression of programmed cell death-1 before primary percutaneous coronary intervention (r=0.8; P=0.0002). A significant proportion of T(EMRA) cells remained depleted for ≥3 months in cytomegalovirus-seropositive patients. Using high-throughput 13-parameter flow cytometry and human leukocyte antigen class I cytomegalovirus-specific dextramers, we confirmed an acute and persistent depletion of terminally differentiated T(EMRA) and cytomegalovirus-specific CD8(+) cells in cytomegalovirus-seropositive patients. Long-term reconstitution of the T(EMRA) pool in chronic cytomegalovirus-seropositive postmyocardial infarction patients was associated with signs of terminal differentiation including an increase in killer cell lectin-like receptor subfamily G member 1 and shorter telomere length in CD8(+) T cells (2225 versus 3397 bp; P<0.001). CONCLUSIONS: Myocardial ischemia and reperfusion in cytomegalovirus-seropositive patients undergoing primary percutaneous coronary intervention leads to acute loss of antigen-specific, terminally differentiated CD8 T cells, possibly through programmed cell death-1–dependent programmed cell death. Our results suggest that acute myocardial infarction and reperfusion accelerate immunosenescence in cytomegalovirus-seropositive patients. Lippincott Williams & Wilkins 2015-01-02 2014-12-31 /pmc/articles/PMC4280279/ /pubmed/25385851 http://dx.doi.org/10.1161/CIRCRESAHA.116.304393 Text en © 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wolters Kluwer. © 2014 The Authors. Circulation Research is published on behalf of the American Heart Association, Inc., by Wolters Kluwer. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Track Hoffmann, Jedrzej Shmeleva, Evgeniya V. Boag, Stephen E. Fiser, Karel Bagnall, Alan Murali, Santosh Dimmick, Ian Pircher, Hanspeter Martin-Ruiz, Carmen Egred, Mohaned Keavney, Bernard von Zglinicki, Thomas Das, Rajiv Todryk, Stephen Spyridopoulos, Ioakim Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients |
title | Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients |
title_full | Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients |
title_fullStr | Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients |
title_full_unstemmed | Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients |
title_short | Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients |
title_sort | myocardial ischemia and reperfusion leads to transient cd8 immune deficiency and accelerated immunosenescence in cmv-seropositive patients |
topic | Clinical Track |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280279/ https://www.ncbi.nlm.nih.gov/pubmed/25385851 http://dx.doi.org/10.1161/CIRCRESAHA.116.304393 |
work_keys_str_mv | AT hoffmannjedrzej myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT shmelevaevgeniyav myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT boagstephene myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT fiserkarel myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT bagnallalan myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT muralisantosh myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT dimmickian myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT pircherhanspeter myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT martinruizcarmen myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT egredmohaned myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT keavneybernard myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT vonzglinickithomas myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT dasrajiv myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT todrykstephen myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients AT spyridopoulosioakim myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients |